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Bacteriophages play an important role in the pathogenicity of Staphylococcus
aureus (S. aureus) either by carrying accessory virulence factors or several super-
antigens. Despite their importance, there are not many studies showing the actual
distribution of the virulence genes carried by the prophages obtained from the
clinically isolated Staphylococcus. In this study, we investigated prophages obtained
from methicillin-resistant S. aureus (MRSA) strains isolated from hospital- and
community-associated (HA-CA) infections for the virulence factors. In the study,
43 phages isolated from 48 MRSA were investigated for carrying toxin genes
including the sak, eta, lukF-PV, sea, selp, sek, seg, seq chp, and scn virulence genes
using polymerase chain reaction (PCR) and Southern blot. Restriction fragment length
polymorphism was used to analyze phage genomes to investigate the relationship
between the phage proﬁles and the toxin genes’ presence. MRSA strains isolated from
HA infections tended to have higher prophage presence than the MRSA strains
obtained from the CA infections (97% and 67%, respectively). The study showed that
all the phages with the exception of one phage contained one or more virulence genes
in their genomes with different combinations. The most common toxin genes found
were sea (83%) followed by sek (77%) and seq (64%). The study indicates that
prophages encode a signiﬁcant proportion of MRSA virulence factors.
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Introduction
Staphylococcus aureus (S. aureus) is responsible for many hospital- and
community-associated (HA-CA) infections [1]. Methicillin-resistant S. aureus
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(MRSA) appeared in 1960 and became an important healthcare problem over the
following years [1–3]. It is virulent and resistant to antimicrobials [4]. S. aureus
can produce more than 30 different extracellular proteins [1]. Most of them have
been described and characterized, such as the staphylokinase (SAK), the chemo-
taxis inhibitory protein (CHIP), the staphylococcal inhibitor of complement
(SCIN), and several superantigens including SEA, SEG, SEK, SEP, and SEQ [5, 6].
These superantigens are enterotoxin. They may cause food poisoning, toxic shock
syndrome, and necrotizing fasciitis. Panton–Valentine leukocidin (PVL, encoded
by lukF-PV, lukS-PV) is cytotoxin. PVL creates pores into leukocytes and cause
necrotic infections. The exfoliative toxin A (ETA) is involved in severe skin
infections [7].
The staphylococcal virulence factors are mostly encoded by genetic ele-
ments such as prophages, transposons, plasmids, and pathogenicity islands [8].
Most likely due to horizontal transfer, these mobile elements are not found equally
among clinical isolates, and there are signiﬁcant variations between different
strains [8, 9].
The vast majority of bacteria contain prophages, which cause substantial
genetic variability. It is known that they constitute major vehicles for horizontal
gene transfer [5, 10].
During the past decade, sequencing of Staphylococci genomes and improve-
ments in the comparative genomic analyses has signiﬁcantly increased the number
of staphylococcal phages identiﬁed. To date, more than 68 Staphylococci phages
and prophages’ sequences, mainly from S. aureus, are identiﬁed [5].
All S. aureus genomes sequenced so far do contain at least one prophage,
and many strains contain up to four [5]. These encode numerous staphylococcal
toxins responsible for pathogenesis [8, 9]. Despite their importance, there are not
many studies showing the actual distribution of the toxin genes carried by the
prophages obtained from the clinically isolated Staphylococcus. A comprehensive
picture of the distribution of virulence factors carried by the prophages in the
S. aureus strain populations was lacking. A study showed that the MRSA isolates
harbored more superantigenic toxin genes than the MSSA isolates [11]. In this
study, 43 phages isolated from 48 MRSA were investigated for carrying toxin
genes including the sak, eta, lukF-PV, sea, selp, sek, seg, seq chp, and scn toxin
genes. We also analyzed the phages using restriction fragment length polymor-
phism (RFLP) and investigated the relationship between the phage proﬁles
and the toxin genes’ presence. Although our approach does not allow drawing
exact conclusions whether the found virulence genes are present on a single
phage or are distributed on different phages, the analyses showed that 95% of all
phages contain one or more toxin genes in their genomes with different
combinations.
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Materials and Methods
Study strains
Forty-eight S. aureus strains isolated from hospitalized patients, and
outpatients of different clinics of the Haydarpasa Numune Teaching and
Research Hospital, Istanbul, Turkey, in 2004 and 2005, were included in the
study (Table I). The isolates were identiﬁed as S. aureus by conventional
methods (Gram stain morphology, catalase and DNase production) and were
conﬁrmed by the production of clumping factor and polyclonal IgG antibodies
against protein A and capsular polysaccharide (Staphytect test; Oxoid Ltd.,
Basingstoke, Hampshire, England). Methicillin resistance was detected with the
mecA gene with PCR and conﬁrmed with the conventional method, the oxacillin
disk diffusion test [12]. S. aureus ATCC 25923 and S. aureus ATCC 700699
Table I. MRSA isolated from samples, clinics, and presence of phage
Samples Clinics MRSA Prophage
Tracheal
aspirates
Reanimation H412, H385, H413, H459,
H350, H143
+
Tracheal
aspirates
Reanimation-2 H1057, H1003, H971,
H895
+
Catheter samples Reanimation-2 H410, H807 +
Blood culture Reanimation H328, H391 +
Tracheal
aspirates
Neurosurgery H318, H370, H345, H389,
H477, H1046
+
CSF Neurosurgery H487, H376 +
Catheter samples Neurosurgery H479, H378, H201 +
Pus Surgery H31 +
Peritoneal ﬂuid General surgery-2 H302, H481 +
Blood culture General surgery-4 H715 +
Blood culture Dialysis unit H421 +
Blood culture Neurology H435 +
Blood culture Medicine H475, H464 +
Sputum Medicine H3 +
Ear secretion ENT surgery H368 +
Urine samples Outpatient – obstetrics and gynecology C3, C90, C52 +
Nose secretion Dermatology C33 +
Urine samples Outpatient – urology C9, C54, C66 +
Joint ﬂuid Outpatient – orthopedic C46 +
Joint ﬂuid Outpatient – orthopedic C24 −
Urine samples Outpatient – urology C71 −
Ureter secretion Outpatient – urology C17 −
Urine samples Outpatient – urology C64 −
Blood culture Reanimation H623 −
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(Mu50) strains were used as methicillin-susceptible and methicillin-resistant
standard controls, respectively.
Isolation of phage particles
The method of Kaneko et al. [13] was used with some modiﬁcations.
Brieﬂy, after cultivating bacteria in heart infusion broth on a shaker at 37 °C for
3 h, mitomycin C (MMC) was added at a ﬁnal concentration of 1 μg/mL of the
mid-exponential phase and cultivation was continued for 5 h. Bacteria were
centrifuged at 10,000 × g for 15 min, and the supernatant was ﬁltered twice
through a 0.2-μm ﬁlter. The phage-containing supernatant was treatedwithDNase I
and RNase A (1 μg/mL; Sigma-Aldrich Corp., St. Louis, MO) at room temperature
for 1 h, and then polyethylene glycol 6000 at a ﬁnal concentration of 10% (w/v) was
added. After incubation for 12 h at 4 °C, phage particles were recovered by
centrifugation at 11,000× g for 10 min and suspended in 1 mL TE buffer and
used for preparing the phage genomic DNA.
Phage DNA extraction
Enzymatic digestion by proteinase K (100 μg/mL) was performed for
5 h (55 °C) in 1 mL of lysis buffer (0.1 mol/L NaCl; 0.21 mol/L Tris–HCl;
0.05 mol/L ethylenediaminetetraacetic acid, pH 8; 0.5% sodium dodecyl
sulfate). DNA extraction was then carried out using a phenol–chloroform
(1/2; 1/2) extraction [14]. The DNA was then precipitated with absolute ethanol
(two volumes) and resuspended in 100 μL of ddH2O [14].
Screening and analysis of toxin genomes with PCR
The designed sequences of the primers and the expected size of the
PCR products are shown in Table II. Table II also shows GenBank accession
number of the individual toxin gene sequences in which primers were chosen.
PCR ampliﬁcation was performed in a total of 50 μL containing 10 ng of the
DNA template, 20 pmol of each primer, 2.5 mmol/L of the four deoxynucleo-
tides, and 2.5 U of Taq polymerase (Fermentas, Lithuania). The reaction
mixtures were subjected to 38 cycles of ampliﬁcation in GeneAmp 2400
(PE Applied Biosystems, Foster City, CA). After ampliﬁcation, the PCR
products were analyzed by ethidium bromide (EtBr)-treated agarose gel
electrophoresis.
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Cloning and sequencing of PCR products
The PCR products were cloned into a pGEM-T vector (Promega, Madison,
WI, USA) according to the manufacturer’s instructions. The recombinant plasmids
were transfected into Escherichia coli DH5α, and the resulting recombinants were
screened by the colony PCR method with the vector and insert DNA primers.
Nucleotide sequencing of the insert DNA was performed by BigDye Terminator
(PE Applied Biosystems, Foster City, CA, USA) sequencing chemistry on an
automatic DNA sequencer (ABI 377; Applied Biosystems, Foster City, CA, USA).
Sequences obtained were subjected to a BLAST search with registered sequences in
the GenBank database for the conﬁrmation of the PCR product.
Southern blot
The toxin genes’ positive and one or more toxin genes’ negative phage
genomes were cut with HinfI enzyme and run on agarose gel. After transferring to
the PVDF blotting membrane, Southern blot was completed with hybridization of
biotin-labeled toxin primer probes. The gene primers were labeled with
Table II. The name of the virulence genes, designed sequences of the primers, the expected size of the PCR
products, and GenBank accession number of the individual toxin gene sequences
Virulence
gene Primer sequence
Size of the PCR
product (bp)
GenBank
accession number
SAK 5′ TGTGACTGGAGTTGATGGTAC 3′
5′ TGCCATCTAATGCCCATTCGAC 3′
140 KC342645
PVL 5′ CTCGGAGTCCAAAGATTCTG 3′
5′CCTATCAATCGTAGTTCTGTAGC3′
245 AB218700.1
ETA 5′ GTTATTCAAGACGAACTGATG 3′
5′ TAACACACCAGTTGCACTTG 3′
230 AP001553
SCIN 5′ AGCACAAGCTTGCCAACATCG 3′
5′ TTAATATTTACTTTTTAGTGC 3′
225 CP005288
CHIPS 5′ TCAGCAAGTGGTGTATTCAG 3′
5′ ACACACCATCATTCAGCGAAAG 3′
250 EF462199
SEA 5′ GCATGTATGGTGGTGTAACG 3′
5′ TGAATTCTGTCCTTGAGCAC 3′
292 GQ859135
SEIP
(SEP)
5′ TTATGGTTATCAATGTACTG 3′
5′ AATCATAACCAACCGAATCA 3′
300 EF534985
SEK 5′ CTCCTATAGCTAATCAACTAC 3′
5′ TGTATTCTTCTTGAAGGTAC 3′
315 CP003166
SEG 5′ ATACGTCTCCACCTGTTGAAG 3′
5′ GTCGATTGTTACCTGTACAG 3′
295 CP006044
SEQ 5′ CTGATATCCATATTCCTGAC 3′
5′ TCTACTTCTCATCAATTAGAG 3′
335 GU723683
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biotinylated dNTPs according to the manufacturer’s protocol (North2South Biotin
Random Prime DNA Labeling Kit; Pierce Biotechnology, Rockford, IL) and used
as probes. The hybridization and detection were done by following the protocol of
the North2South Chemiluminescent Hybridization and Detection Kit (Pierce
Biotechnology), which uses a streptavidin–horseradish peroxidase coupled anti-
body for detection.
RFLP analysis of phage DNAs
Phage DNAs were cut with HinfI restriction enzyme and run through an
EtBr-treated gel and were visualized and photographed.
Results
Isolation of phage particles
Forty-eight MRSA strains were examined for prophages. Bacterial cells
in the logarithmic phase of growth were treated with MMC. For the prevention
of possible bacterial DNA and RNA contamination, the phage-containing
supernatant was treated with DNase and RNase. DNAs were extracted and
run on agarose gel. It was found that 43 of the 48 MRSA strains contain phage-
related DNA (Table I). No phage was obtained from the ﬁve MRSA isolates.
One out of thirty-six MRSAs isolated from the HA infections contain phages
and four out of twelve MRSAs isolated from the CA infections contain phages
(Table I).
Detection of the toxin genes from phage genome
The existence of the toxin genes in the phage genomes was examined by
the PCR method. Figure 1A shows the PCR results of the SCN toxin gene as a
representative of the PCR results. Subsequently, the PCR products of each of
individual genes were cloned into the pGEM-T vector and were sequenced. The
sequences were compared with other DNA sequences in the GenBank database,
using a BLAST search. Because of the possibility of the bacterial nucleic acids
contamination, the Southern blot was performed for all the PCR positive
phages. The toxin genes’ positive and one or more toxin genes’ negative
phage genomes were cut with HinfI enzyme and run on agarose gel. After
transferring to the PVDF blotting membrane, Southern blot was completed with
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the hybridization of biotin-labeled toxin primer probes. Figure 1B
shows the results of the Southern blot of the SCN toxin gene as a representative
of the Southern blot results. With the exception of one phage in which
MRSA was isolated from the CA infection, all the phages contained toxin
genes in their genome (Table III). Two phages contained one toxin gene, and
the rest of the phages contained two or more toxin genes in their genomes. In
one of the phages, six of the ten different toxin genes searched in this study
were found. The most common toxin genes found in the phages were sea 83%,
followed by sek (77%), and seq (64%). LukF-PV and selp were not found in
the 43 phages. It is found that only 1 of the 43 phages carries eta gene
(Table III).
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Figure 1. (A) The PCR results of SCIN toxin gene using template DNAs obtained from the phages.
(B) Southern blot results using SCN primers labeled with biotinylated dNTPs. All the SCN toxin
genes’ positive with PCR and H1057 as negative phage genome were analyzed. The PCR product of
SCN was used as positive control. H and C correspond to hospital- and community-associated
infections, respectively. M corresponds to 1 kb DNA ladder
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Table III. Bacteriophages were grouped according to the RFLP analysis and the virulence genes carried by
the individual phage were shown
Phage
group
MRSA
with
Virulence genes
no. phage SAK ETA PVL SEA SEIP SEK SEG SEQ CHIP SCN
1 H1057 + − − + − + − + − −
2 C33 + − − − − − − − + −
H302 + − − + − + − + + −
3 H412 − − − + − + − + − −
H413 − − − + − + − + − −
H475 − − − − − + − + − −
H368 − − − + − + − + + −
H971 − − − + − + − + + −
H345 − − − + − + − + + −
H481 − − − + − + − + − −
H391 − − − + − + − + + −
4 H487 + − − + − + − + − −
5 H385 − − − + − + − − − −
H459 − − − + − + − + − −
H378 + − − + − + − + − +
H3 − − − + − + − + − −
H715 + − − + − + − + − −
H376 + − − + − + − + − +
H318 + − − + − + − − + +
H143 + − − + − + − + + −
H370 − − − + − + + − −
H807 + − − + − + − + + −
H421 − − − + − + − + − −
H477 + − − + − + − + − −
H1003 − − − + − + − − − +
H895 − − − + − + − − − −
H1046 − − − + − + − − − −
6 H350 + − − + − + − + − −
7 C3 + − − + − + − + − −
8 C9 + − − + − − − − + +
9 C66 − − − + − − − − − −
11 H410 + − − + − − + − − +
12 C46 + − − + − − + − + +
13 H328 + − − + − + − + + +
14 H31 + − − + − − + − + +
15 C54 + − − + − − + − + +
16 H464 + − − − − − − − − −
18 C90 − − − − − − − − − −
19 H479 + − − + − + − + − +
20 H201 + − − + − + − + − +
21 C52 − − − + − − − − + −
22 H389 + − − + − + + + −
23 H435 + + − − − + + − − +
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RFLP analysis of phage genomes
RFLP was used to analyze phage genomes to investigate the relationship
between the phage proﬁles and the toxin genes’ presence. Initially, phage
genomes were cut with the EcoRI, HindIII, and HinfI restriction enzymes (data
not shown). HinfI digestion presented the best discrimination among the DNAs.
The RFLP of phage genomes were repeated two or more times. The RFLP
analysis of 43 phages displayed 23 proﬁles (Figure 2 and Table III). Two major
groups were obtained: phage groups #3 and #5. The group #5 contained
15 phages according to the visual analysis of phages’ RFLP. In the group #5, all
15 phages contained the sea and sek, 10 of the 15 contained the seq, 7 of the 15
contained the sak, 4 of the 15 contained the scn; 3 of the 15 contained the chp toxin
genes (Table III). The phage group #3 contained eight phages. All the eight phages
contained the sek and seq, seven of the eight contained the sea, and three of the eight
contained the chp toxin genes in their genomes. The other phages contained
different combinations of toxin presence (Table III). The RFLP analysis of all the
phage genomes showed that the ETA-containing phage and the phage carrying six
virulence genes are quite different from the rest of the phage genomes (Figure 2).
Discussion
The bacteriophages play an important role in the pathogenicity of S. aureus
either by carrying accessory virulence factors such as PVL, SAK, and ETA or
several superantigens [15]. In addition to toxins, phages carry immune evasion
clusters (IECs) including SCIN and CHIPS [16]. Despite their importance, a
comprehensive picture of the distribution of virulence factors carried by the
prophages in the S. aureus strain populations was lacking. In this study, we
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Figure 2. RFLP analyses of bacteriophages’ DNAs obtained fromMRSA isolates. The phage DNAs
were digested with HinfI and analyzed on a 0.9% agarose gel. M corresponds to lambda/HindIII
ladder. H and C correspond to hospital- and community-associated infections, respectively
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investigated prophages obtained from MRSA strains isolated from HA and CA
infections for the virulence factors. Interestingly, MRSA strains isolated from HA
infections tended to have higher prophage presence than the MRSA strains
obtained from the CA infections (97% and 67%, respectively). With the exception
of one phage obtained from MRSA which was isolated from the CA infections, all
other 42 phages contained one or more virulence genes in their genomes. The most
common toxin genes found were the sea (83%) followed by the sek (77%) and seq
(64%). SEs are a family of major serological types of heat-stable enterotoxins
(SEA through SEE and SEG through SEQ). SEs function both as potent
gastrointestinal toxins as well as superantigens that stimulate non-speciﬁc T-cell
proliferation. SEA was found as the most common toxin especially in staphylo-
coccus-related food poisoning [17].
Although we primarily evaluated the presence of the virulence genes in
phages obtained from MRSA, we also analyzed the phages using the RFLP and
investigated the relationship between the phage proﬁles and the toxin genes’
presence. Visual analysis of the phages’ RFLPs revealed two major groups: phage
groups #3 and #5. The phage goup #5 contained 15 phages. All 15 phages carried
the sea and sek toxin genes, 10 of the 15 phages carried the seq toxin gene, and 7 of
15 phages carry the sak toxin gene. The phage group #3 contained eight phages
and none of the phages carry the sak gene. Although the combinations of the toxin
genes in the groups were similar, there are some differences. For example, only
three of the samples in group #5 carried the scn toxin gene. Since all 15 RFLP
phage proﬁles look the same, we expected to see the same combinations of toxin
genes. This unexpected ﬁnding might be related to bacteria which may contain
more than one phage in their genome. Similarly, it was shown that eight different
families are prevalent in S. aureus and φ3 bacteriophage is the most prevalent
bacteriophage [18]. In addition, it was shown that φ3 bacteriophage carries
different combinations of the virulence genes [18, 19]. Although our approach
does not allow drawing conclusions whether the found virulence genes are present
on a single phage or are distributed on different phages, we may conclude that
group #5 contains the same prophage or prophages. In addition, a series of discrete
15–20 kb chromosomal elements that encode SEs and reside at speciﬁc locations
were identiﬁed [8]. These are referred to as staphylococcal pathogenicity islands
(SaPIs). It was shown that some SaPIs are mobilized by staphylococcal trans-
ducing phages [20]. These SaPIs were detected together with the phage DNA on
the agarose gel [8]. This may particularly explain the differences of toxin genes’
proﬁles and discrepancy in RFLP.
The gene encoding SCIN (scn) was shown as to be a part of IEC [21]. Seven
IEC variants have been identiﬁed [22]. All IEC variants carry scn and a different
combination of sea, sak, and chp. The scn and chp genes are found in 6/7 and
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3/7 sequenced S. aureus strains, respectively [16]. Analyses of these sequenced
genomes showed that both the scn and chp are carried by β-hemolysin (hlb)-
converting bacteriophages (βC-φs) [16]. In 90% of strains from a genetically
diverse clinical S. aureus strain collection, a βC-φ was found that carries one of the
seven IEC variants. It is also indicated that βC-φs contain common sequence such as
scn in their genome and βC containing phages might be different from each other. In
this study, it was found that only 13 of the 43 phages contained scn in their genome
and 16 of the 43 phages carry chp. Therefore, it may be concluded that CHIPS are
not found only in the βC-φs and combination with the SCIN in IEC variants.
SAK is a bacterial plasminogen activator [21, 23]. Different studies
observed that staphylococci coming from different samples contain up to 80%
sak gene in their chromosomes [23]. It is also observed that there is a clear
correlation between producing sak and belonging of a strain to a bacteriophage
group [15, 23]. In addition, these strains do not constitute a homogenous group,
and they belong to different phage types [23]. The results of our study showed that
55% of the phages contained the sak gene. Similar to the previous study, we also
observed that different phage types may contain the sak gene. Although we do not
know the characteristics of group #3, which contained seven phages, none of the
phages contained the sak gene. This may conclude that the sak gene is carried with
different combinations of gene clusters in addition to IEC in the different phages.
PVL, a pore-forming cytotoxin selectively disrupts leukocyte membranes,
leading to increased virulence. In the late 1990s, the ﬁrst PVL-positive MRSA
isolates were observed and such strains have spread globally in recent years [24].
The presence of lukF-Pv shows diversity depending on different factors. For
example, a higher proportion of S. aureus strains (both MSSA and MRSA strains)
that were derived from skin and soft tissue infection contain the lukF-PV gene
compared to the S. aureus strains isolated from blood [25]. In addition to that,
more CA-MRSA genotypes contain the lukSF-PV gene compared to the
HA-MRSA [26]. It was also shown that lukF-Pv carrying phages contain fewer
enterotoxin genes than strains without lukF-PV [25, 26]. In this study, none of the
43 phages contain the lukF-PV gen. This may particularly be explained by the
number of the CA-MRSA used in the study. Although 12 CA-MRSA were
screened, only eight of them contain the phages. In addition to that, in our results,
96% of the phages contained more than one toxin in their genome.
The eta gene encoding ETA is previously believed to be located on the
chromosome of S. aureus, whereas the gene for ETB is located on a large plasmid
[27–30]. Yoshizawa et al. [31] described, for the ﬁrst time, a temperate phage that
carried the structural gene for ETA from an ETA-producing strain of S. aureus.
Yamaguchi et al. [32] also isolated a phage (φ ETA) that encodes an ETA from
S. aureus, isolated from a human impetigo patient, and determined the complete
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nucleotide sequence of the φ ETA genome. Recently, we isolated an eta gene
carrying phage obtained from MRSA strain isolated from the blood of the patient
without any skin lesion [33]. Both in the previous study and this study, we showed
that the MRSA φ ETA genome was different from the genomes of the other
phages. In addition to differences of MRSA φ ETA, we previously showed that
ETA-carrying MRSA isolate is also quite different from the other MRSA isolates
examined in the study. In addition to this, toxin genes’ proﬁle is unique compared
to the other phages’ toxin proﬁles.
Enterotoxin gene, seq, encodes pyrogenic toxin superantigens that lack
emetic activity in monkeys, a deﬁning biological feature of classical staphylococ-
cal enterotoxins [34]. Molecular analyses indicate that early MSSA and MRSA
strains may acquire pathogenicity island (SaPI) 3, which contains the genes for
three potent enterotoxins, seb, sek, and seq [35]. The sek and seq were adjacent
genes in the S. aureus, separated by only 15 nucleotides, and also encoded similar
predicted amino acid sequences [35]. Similarly, we found that 27 seq toxin genes
containing phages also carry the sek gene.
The staphylococcal enterotoxin-like toxin type P (SElP) is a novel SE-
related toxin gene. It was identiﬁed as sep after the full genome sequencing of the
S. aureus N315 strain [36]. A recent study showed that SEIP found only 3 of the
481 strains of S. aureus carried with prophages [37]. In this study, we found that
neither of the phage carries selp gene. Therefore, selp carriage is relatively low
compared to the other superantigens. It may be concluded that speciﬁc clusters or
phages in restricted S. aureus strains carry selp.
Herein, we analyzed the phages obtained only from MRSAs. A study
showed that there are superantigenic toxin genotypes in both MRSA, and MSSA
isolates from clinical specimens. Of the 118 MRSA isolates, all strains were
diagnosed as positive for superantigenic toxin genes. In contrast to the MRSA
isolates, 34 isolates (24.3%) of the 140 MSSA isolates were diagnosed as negative
for superantigenic toxin genes [11]. Therefore, MRSAs have the tendency for
carrying toxin genes more than MSSAs.
In conclusion, although only 10 virulence factors were searched, this study
indicates that prophages encode a large proportion of MRSA virulence factors and
provide the pathogen with a large variety of toxins. Although our approach does
not allow drawing conclusions whether the found virulence genes are present on a
single phage or are distributed on different phages, it may indicate that toxin genes
are carried in the different phages possibly with different gene clusters. Though the
techniques used by us may not have allowed the identiﬁcation of all the toxin
genes we searched for and some of the genes detected could have been located on
genetic islands (as indicated above), our ﬁndings clearly demonstrate the relevant
differences between the toxin genes’ content of CA-MRSA and HA-MRSA
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isolates and between various groups of phages. Obviously, further characterization
of the whole genome of strains and phages will give more information for non-
inducible phages and SaPIs.
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